Renk's Record 582 Million Euro Quarter Overshadowed by 100 Million Euro Israel Cloud and Short Seller Advance
20.05.2026 - 09:36:45 | boerse-global.de
The Renk Group finds itself in a peculiar tug-of-war. Management is touting a record order intake at the International Investment Forum today, yet the stock languishes near a 52-week low, hammered by a combination of profit-taking, geopolitical risk, and a growing coterie of institutional short sellers. The gap between operational strength and market sentiment has rarely been wider for the Augsburg-based defense specialist.
First-quarter figures paint a picture of a company firing on all cylinders. Order intake surged 6.1% to €582 million — the highest ever recorded in a first quarter — lifting the total backlog to approximately €6.9 billion. More than 90% of the planned 2026 revenue is already secured by existing contracts. Adjusted operating profit climbed to just over €42 million, with the operating margin improving to 15%. Management reaffirmed its full-year guidance: revenue above €1.5 billion and adjusted EBIT between €255 million and €285 million.
Yet the shares closed Tuesday at €45.67, a whisker above the 52-week trough of €43.91 hit in mid-May and nearly 50% below the October peak. The recent sell-off reflects not only a broader rotation out of European defense names — where profit-taking and tepid expectations for further budget increases have weighed — but also company-specific headwinds.
Should investors sell immediately? Or is it worth buying Renk?
On the short side, two major funds have taken aim. Citadel Advisors recently disclosed a net short position of 0.5%, while PDT Partners raised its bet from 0.79% to 0.84%. Together they underscore a deepening bearish conviction. However, the negative bets are not going uncontested. BlackRock, the world’s largest asset manager, increased its voting rights stake to 4.44%, suggesting long-term institutional investors see value in the dip.
The skeptics have concrete reasons for caution. Renk supplies components for Israeli tanks, and potential export restrictions could put as much as €100 million of this year’s revenue at risk. Additional timing issues have delayed roughly €200 million in sales from the previous year into the first half of 2026. The market is pricing in these political and operational uncertainties, even as the company insists the full-year target remains achievable.
Management is attempting to bolster confidence through continuity. The supervisory board extended CEO Dr. Alexander Sagel’s contract by five years, through 2032 — a clear vote of stability. At the virtual annual general meeting on June 10, shareholders will vote on a proposed dividend of €0.58 per share for fiscal 2025, a 38% increase from the prior year, and on the election of Dr. Klaus Richter as the new supervisory board chairman, replacing Claus von Hermann who is stepping down voluntarily.
The AGM offers Renk’s leadership a chance to bridge the chasm between record backlogs and a depressed stock price. With the record order book, a rising dividend, and a refreshed board, the question is whether the market will eventually look past the short-term risks — or whether the short sellers’ thesis, anchored on the Israel exposure and delayed revenues, will continue to hold sway.
Ad
Renk Stock: New Analysis - 20 May
Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Renks Aktien ein!
FĂĽr. Immer. Kostenlos.
